Skip to Main Content

Paper Details

Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504).
JTO Clin Res Rep
4
2021
Author NameAffiliation
Jyoti MalhotraRutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University
  • 1 - 1

Datasets

Release 1.2